Bafnapharm Q4 Results

  • BSE: 532989
  • NSE: BAFNAPH
  • ISIN: INE878I01022
  • Sector: Biotechnology & Drugs
BSE
81.741.74 (2.18%)
Volume51.00
Updated: Mon 25 Nov, 2024 | 15:17:01
NSE
800.00 (0.00%)
Volume137.00
Updated: Mon 25 Nov, 2024 | 15:17:10
Today: 80.10
81.74
52-Wk: 73.35
112.20

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Bafnapharm Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 41.4034.22-%42.24-%
    Selling/ General/ Admin Expenses Total 5.383.92-%4.71-%
    Depreciation/ Amortization 1.271.40-%1.53-%
    Other Operating Expenses Total 4.902.24-%1.73-%
    Total Operating Expense 39.7832.07-%35.81-%
    Operating Income 1.622.15-%6.44-%
    Net Income Before Taxes 1.462.99-%5.65-%
    Net Income 1.462.99-%5.37-%
    Diluted Normalized EPS 0.621.26-%2.44-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts